House Democrats handed the president one of his biggest legislative victories, unveiling an updated North American trade deal just an hour after announcing two articles of impeachment against the president.
Democrats and the White House finalized a deal after a year of going back and forth to create a replacement for the North American Free Trade Agreement (NAFTA). The new legislation strengthens worker protections and includes provisions on the environment, big pharma, and enforcement. The United States-Mexico-Canada Agreement (USMCA) was signed more than a year ago and now the changes will be voted on in the House and the Senate. The revisions then need the signature of the U.S. president and the expected approval from Mexico and Canada.
"This is a day we've all been working to, and working for, on the path to yes," House Speaker Nancy Pelosi said.
"We were in range for a while but until we could cross a certain threshold of enforcement for our workers' rights, for the environment, and for the prescription drug issue, as you know, they were three of the areas that we had put out there," Pelosi explained.
She said the new trade agreement is "much better" than NAFTA and "infinitely better than what was initially proposed by the administration."
House Ways and Means Committee Chairman Richard Neal (D-Mass. 1st District) said it is rare to participate in a "never happen moment and we are witnessing that today." Neal led talks with the administration and said the new deal was a "triumph" for U.S. workers. Democrats negotiated policy changes particularly on prescription drug pricing, protection for workers, and the environment.
The President weighed in on Twitter and said: "America's great USMCA Trade Bill is looking good."
To applause, Rep. Jan Schakowsky (D-Ill. 9th District) said the "new and improved" deal "prevents big pharma from raising the price of prescription drugs across the United States, Mexico, and Canada… we eliminated provisions that undermine Congress' ability to change domestic policy that lead to high drug prices."
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
Former Cisco Systems CEO John Chambers learned all about technology’s volatile highs and lows as a veteran of the internet’s early boom days during the late 1990s and the ensuing meltdown that followed the mania. And now he is seeing potential signs of the cycle repeating with another transformative technology in artificial intelligence. Chambers is trying take some of the lessons he learned while riding a wave that turned Cisco into the world's most valuable company in 2000 before a crash hammered its stock price and apply them as an investor in AI startups. He recently discussed AI's promise and perils during an interview with The Associated Press.
Grove Collaborative’s CEO shares how the company is reinventing everyday goods with sustainability at the core and working toward a plastic-free future.
Atlanta Mayor Andre Dickens shares plans for affordable housing, community-led growth, and why private and public grocery stores could be key to food equity.
Tesla reported a surprise increase in sales in the third quarter as the electric car maker likely benefited from a rush by consumers to take advantage of a $7,500 credit before it expired on Sept. 30. The company reported Thursday that sales in the three months through September rose 7% compared to the same period a year ago. The gain follows two quarters of steep declines as people turned off by CEO Elon Musk’s foray into right-wing politics avoided buying his company’s cars and even protested at some dealerships. Sales rose to 497,099 vehicles, compared with 462,890 in the same period last year.
Tom’s Guide Editor-in-Chief Mark Spoonauer breaks down Apple & Amazon's latest product drops—what's hot, what's hype, and what really matters for users.
